Cargando…
The Clinical Impact of CLIR Tools toward Rapid Resolution of Post-Newborn Screening Confirmatory Testing for X-Linked Adrenoleukodystrophy in California
Since the start of X-linked adrenoleukodystrophy (ALD) newborn screening in California, more than half of the diagnosed cases were found to have an ATP binding cassette subfamily D member 1 (ABCD1) gene variant of uncertain significance (VUS). To determine retrospectively the likelihood that these w...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570356/ https://www.ncbi.nlm.nih.gov/pubmed/33123639 http://dx.doi.org/10.3390/ijns6030062 |
_version_ | 1783596930109014016 |
---|---|
author | Tang, Hao Matteson, Jamie Rinaldo, Piero Tortorelli, Silvia Currier, Robert Sciortino, Stanley |
author_facet | Tang, Hao Matteson, Jamie Rinaldo, Piero Tortorelli, Silvia Currier, Robert Sciortino, Stanley |
author_sort | Tang, Hao |
collection | PubMed |
description | Since the start of X-linked adrenoleukodystrophy (ALD) newborn screening in California, more than half of the diagnosed cases were found to have an ATP binding cassette subfamily D member 1 (ABCD1) gene variant of uncertain significance (VUS). To determine retrospectively the likelihood that these were true positive cases, we used a web-based post-analytical tool in Collaborative Laboratory Integrated Reports (CLIR). Confirmatory plasma very long-chain fatty-acids (VLCFA) profiles for ALD screen positive infant boys were run through the CLIR ALD tool. We compared the distribution by ABCD1 variant classification (pathogenic, likely pathogenic, VUS, and no variant) with the CLIR tool score interpretation (non-informative, possibly ALD, likely ALD, and very likely ALD) and the current case diagnosis. The study showed that CLIR tool positive interpretations were consistent with 100% of the pathogenic and likely pathogenic variants on the ABCD1 gene if a more conservative guideline was used. The tool interpretations were also consistent with screened cases that were determined to not have disease (our no-disorder group). The CLIR tool identified 19 diagnosed ALD cases with VUS to be potential false positives, representing a 40% reduction among all diagnosed ALD cases with VUS. The reduction could be extended to 65% if a more aggressive threshold was used. Identifying such preventable false positives could alleviate the follow-up burden for patients, their families, and California Special Care Centers. |
format | Online Article Text |
id | pubmed-7570356 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75703562020-10-28 The Clinical Impact of CLIR Tools toward Rapid Resolution of Post-Newborn Screening Confirmatory Testing for X-Linked Adrenoleukodystrophy in California Tang, Hao Matteson, Jamie Rinaldo, Piero Tortorelli, Silvia Currier, Robert Sciortino, Stanley Int J Neonatal Screen Article Since the start of X-linked adrenoleukodystrophy (ALD) newborn screening in California, more than half of the diagnosed cases were found to have an ATP binding cassette subfamily D member 1 (ABCD1) gene variant of uncertain significance (VUS). To determine retrospectively the likelihood that these were true positive cases, we used a web-based post-analytical tool in Collaborative Laboratory Integrated Reports (CLIR). Confirmatory plasma very long-chain fatty-acids (VLCFA) profiles for ALD screen positive infant boys were run through the CLIR ALD tool. We compared the distribution by ABCD1 variant classification (pathogenic, likely pathogenic, VUS, and no variant) with the CLIR tool score interpretation (non-informative, possibly ALD, likely ALD, and very likely ALD) and the current case diagnosis. The study showed that CLIR tool positive interpretations were consistent with 100% of the pathogenic and likely pathogenic variants on the ABCD1 gene if a more conservative guideline was used. The tool interpretations were also consistent with screened cases that were determined to not have disease (our no-disorder group). The CLIR tool identified 19 diagnosed ALD cases with VUS to be potential false positives, representing a 40% reduction among all diagnosed ALD cases with VUS. The reduction could be extended to 65% if a more aggressive threshold was used. Identifying such preventable false positives could alleviate the follow-up burden for patients, their families, and California Special Care Centers. MDPI 2020-08-05 /pmc/articles/PMC7570356/ /pubmed/33123639 http://dx.doi.org/10.3390/ijns6030062 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tang, Hao Matteson, Jamie Rinaldo, Piero Tortorelli, Silvia Currier, Robert Sciortino, Stanley The Clinical Impact of CLIR Tools toward Rapid Resolution of Post-Newborn Screening Confirmatory Testing for X-Linked Adrenoleukodystrophy in California |
title | The Clinical Impact of CLIR Tools toward Rapid Resolution of Post-Newborn Screening Confirmatory Testing for X-Linked Adrenoleukodystrophy in California |
title_full | The Clinical Impact of CLIR Tools toward Rapid Resolution of Post-Newborn Screening Confirmatory Testing for X-Linked Adrenoleukodystrophy in California |
title_fullStr | The Clinical Impact of CLIR Tools toward Rapid Resolution of Post-Newborn Screening Confirmatory Testing for X-Linked Adrenoleukodystrophy in California |
title_full_unstemmed | The Clinical Impact of CLIR Tools toward Rapid Resolution of Post-Newborn Screening Confirmatory Testing for X-Linked Adrenoleukodystrophy in California |
title_short | The Clinical Impact of CLIR Tools toward Rapid Resolution of Post-Newborn Screening Confirmatory Testing for X-Linked Adrenoleukodystrophy in California |
title_sort | clinical impact of clir tools toward rapid resolution of post-newborn screening confirmatory testing for x-linked adrenoleukodystrophy in california |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570356/ https://www.ncbi.nlm.nih.gov/pubmed/33123639 http://dx.doi.org/10.3390/ijns6030062 |
work_keys_str_mv | AT tanghao theclinicalimpactofclirtoolstowardrapidresolutionofpostnewbornscreeningconfirmatorytestingforxlinkedadrenoleukodystrophyincalifornia AT mattesonjamie theclinicalimpactofclirtoolstowardrapidresolutionofpostnewbornscreeningconfirmatorytestingforxlinkedadrenoleukodystrophyincalifornia AT rinaldopiero theclinicalimpactofclirtoolstowardrapidresolutionofpostnewbornscreeningconfirmatorytestingforxlinkedadrenoleukodystrophyincalifornia AT tortorellisilvia theclinicalimpactofclirtoolstowardrapidresolutionofpostnewbornscreeningconfirmatorytestingforxlinkedadrenoleukodystrophyincalifornia AT currierrobert theclinicalimpactofclirtoolstowardrapidresolutionofpostnewbornscreeningconfirmatorytestingforxlinkedadrenoleukodystrophyincalifornia AT sciortinostanley theclinicalimpactofclirtoolstowardrapidresolutionofpostnewbornscreeningconfirmatorytestingforxlinkedadrenoleukodystrophyincalifornia AT tanghao clinicalimpactofclirtoolstowardrapidresolutionofpostnewbornscreeningconfirmatorytestingforxlinkedadrenoleukodystrophyincalifornia AT mattesonjamie clinicalimpactofclirtoolstowardrapidresolutionofpostnewbornscreeningconfirmatorytestingforxlinkedadrenoleukodystrophyincalifornia AT rinaldopiero clinicalimpactofclirtoolstowardrapidresolutionofpostnewbornscreeningconfirmatorytestingforxlinkedadrenoleukodystrophyincalifornia AT tortorellisilvia clinicalimpactofclirtoolstowardrapidresolutionofpostnewbornscreeningconfirmatorytestingforxlinkedadrenoleukodystrophyincalifornia AT currierrobert clinicalimpactofclirtoolstowardrapidresolutionofpostnewbornscreeningconfirmatorytestingforxlinkedadrenoleukodystrophyincalifornia AT sciortinostanley clinicalimpactofclirtoolstowardrapidresolutionofpostnewbornscreeningconfirmatorytestingforxlinkedadrenoleukodystrophyincalifornia |